CGP 42112,
CGP 42112A,
CGP 42112B,
CGP-42112,
CGP-42112A,
CGP42112,
CGP42112A,
nicotinic acid-Tyr-(N(sigma)-benzyloxycarbonyl-Arg)Lys-His-Pro-Ile-OH,
nicotinic acid-tyrosyl-(N(sigma)-benzyloxycarbonyl-arginyl)lysyl-histidyl-prolyl-isoleucine-OH,
Cgp 42112,
Cgp-42112A,
CGP 42112A,
127060-75-7,
Cgp 42112B,
CGP-42112,
CGP42112A,
Angiotensin II Receptor Ligand,
Nicotinic acid-tyr-(N(sigma)-benzyloxycarbonyl-arg)lys-his-pro-ile-OH,
MFCD00133611,
Nicotinic acid-tyrosyl-(N(sigma)-benzyloxycarbonyl-arginyl)lysyl-histidyl-prolyl-isoleucine-OH,
L-Isoleucine, N-(1-(N-(N6-(N2-((phenylmethoxy)carbonyl)-L-arginyl)-N2-(N-(3-pyridinylcarbonyl)-L-tyrosyl)-L-lysyl)-L-histidyl)-L-prolyl)-,
CGP42112,
(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-[[(2S)-3-(4-hydroxyphenyl)-2-(pyridine-3-carbonylamino)propanoyl]amino]hexanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid,
C52H69N13O11,
[125I]CGP42112,
[125I]-CGP42112,
AC1L3XAY,
GTPL594,
Tyr-Z-Arg-Lys-His-Pro-Ile,
GTPL3944,
CHEMBL1885579,
SCHEMBL15524960,
SCHEMBL16675400,
DTXSID90155396,
3539AH,
PDSP1_000402,
PDSP2_000400,
AKOS024457173,
CS-3414,
NCGC00167317-01,
HY-12405,
LS-183538,
B5316,
CGP-42112A, >=95%, synthetic, solid,
N|A-Nicotinoyl-Tyr-(N|A-Cbz-Arg)-Lys-His-Pro-Ile,
Nalpha-Nicotinoyl-Tyr-(Nalpha-Cbz-Arg)-Lys-His-Pro-Ile,
(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-[[(2S)-3-(4-hydroxyphenyl)-2-(pyridine-3-carbonylamino)propanoyl]amino]hexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid,
D04UJZ,
D0D2MA,
CID123794,
C52-H69-N13-O11,
C060894,